3 
now being received on these revisions, and public hearings are 
scheduled for December 15-16. Witnesses will be invited to give oral 
presentations, while others will also be heard as time permits. Those 
not able to testify may submit written comnents for inclusion in the 
record . 
Members of the Interagency Committee will be invited to attend the 
public hearing, and all relevant briefing documents for the hearing 
will be provided to the Committee members. 
A copy of the revisions has been sent to all industrial representatives 
on record as attending the February 1976 public hearings. The rationale 
for the revisions, as developed by the Recombinant Advisory Committee (RAC), 
will be widely distributed and available upon request. 
Following the analysis of all comments and the transcript of the 
hearings. Dr. Fredrickson will consult with the RAC and others prior 
to reaching any decisions. The final revisions will be published in 
the spring of 1978 along with an EIS if an impact assessment indicates 
that such a statement is needed. 
OSTP Survey 
Dr. Omenn, OSTP, led a discussion of the recent OSTP survey concerning 
the perceived need by Federal agencies for legislation to regulate 
recombinant DNA activities. Of particular interest to the Committee 
[ 373 ] 
